Clinical trial
The Effects of Atorvastatin on Vulnerable Plaques in Untreated Dyslipidemic…
NCT00172419 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00172419 |
|---|---|
| Title | The Effects of Atorvastatin on Vulnerable Plaques in Untreated Dyslipidemic Patients. |
| Official title | Statin-Induced Vulnerable Plaque Regression After Atorvastatin Treatment: Serial Evaluation by 18F-Fluorodeoxyglucose Positron Emission Tomography Study |
| Lead sponsor | National Taiwan University Hospital, Other |
| Collaborators | National Science and Technology Council, Taiwan Pfizer Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hyperlipidemia |
| Intervention type | Drug |
| Interventions | Atorvastatin |
| Enrollment | 43 |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Jan 5, 2009 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: